The world is starting to take notice of the benefits of cannabis and CBD oil, from patients who are seeing a reduction in their medical symptoms to businesses that are recognizing the industry’s profitability. Just recently, an article published in Inc. magazine, indicated the cannabidiol market is estimated to grow by an estimate of 700 percent by 2020. David Spang, the owner of Coastal Green Wellness in Myrtle Beach, South Carolina, said there are more medical studies and research being done on CBD now than ever before.
“CBD stands for cannabidiol, one of the main compounds found in the cannabis plant,” said Spang. “It grows in high percentages in the flowering cannabis sativa L plant varieties.”
Researchers at the University of California San Diego School of Medicine announced a study that should start later this year to determine if and how cannabidiol (CBD) provides therapeutic benefit to children with severe symptoms of autism spectrum disorder (ASD). The clinical trial will comprise 30 children, ages eight to 12, with severe symptoms of autism. In the first phase of the study, half of the children will receive CBD and the other half will receive a placebo. In the second phase, the groups will be switched.
“Another study at the University of California School of Medicine, which should also begin this year, will examine cannabis as a potential treatment for adults who have essential tremors (ET),” added Spang. “We are already seeing positive results from other medical studies about cannabis and CBD oil.”
For example, a study at Washington State University examined how patients who suffer from anxiety and depression were affected by smoking different strains and quantities of cannabis at home. The study found that one puff of cannabis high in CBD and low in THC was optimal for reducing symptoms of depression and two puffs were sufficient to reduce symptoms of anxiety. Ten or more puffs of cannabis high in CBD and high in THC produced the largest reductions in stress.
Spang said the biggest development came last year when the Food and Drug Administration approved Epidiolex, a CBD oil, to treat two rare forms of epilepsy that begin in childhood.
In addition to these medical studies, Spang announced that family practitioners and orthopedists are updating themselves on the benefits of CBD. “At the very least, they are also starting to have conversations with their patients about the benefits,” he said.
“I truly think it’s a grassroots movement. The average consumer is getting good relief from CBD oil and is relaying that information anecdotally to their doctor. Now it has become such a tipping point that the doctors can’t ignore it anymore.”
For more information on CBD products, contact Coastal Green Wellness https://www.coastalgreenwellness.com, located in The Market Common, 2954B Howard Ave, Myrtle Beach, South Carolina 29577; 843-839-3339.
